Wednesday, October 10, 2012

Radius Health osteoporosis study reaches Phase II

 Radius Health, based in Massachusetts says its new transdermal patch technology system could be the new way to deliver osteoporosis medication. Researchers are saying this type of delivery method would not only raise patient compliance, but also make it much easier for patients to take their medication.

The study will include 240 postmenopausal women, and measure changes in bone density over the course of 6 months. The results will becompared with placebo and with BA058-C, a subcutaneous formulation of the samedrug that is in Phase III trials as a daily injection under the skin forfracture prevention in women with severe postmenopausal osteoporosis.Experts are hoping the patch can aid patients with osteoporosis, a market where new drug delivery methods are needed. 

We have been seeing a lot of alternatives to injectable therapies lately, what do you think is next?

Want to learn more about the latest in drug delivery? At DDP, hundreds of pharmaceutical and drug delivery thought leaders come together to develop partnerships to create the next great product that will bring relief to millions of patients. Sign up for updates on the 17th Annual Drug Delivery Partnerships Conference taking place February 6-8, 2013, in San Diego, CA.

No comments:

Post a Comment